E-Health Portal for Individualized Treatment Monitoring and Patient Engagement in Oncology Research
1 other identifier
observational
106
1 country
1
Brief Summary
Evaluation of patient acceptance and characterization of response behaviour for web-based compared with respective paperbacked patient reported outcomes.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jun 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 12, 2017
CompletedFirst Posted
Study publicly available on registry
April 28, 2017
CompletedStudy Start
First participant enrolled
June 1, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 17, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
July 17, 2024
CompletedJanuary 22, 2025
December 1, 2024
7.1 years
April 12, 2017
January 17, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
QLQ-C30 questionnaire for baseline
Overall patient completion rate in the paperbacked questionnaire and the web-tool, respectively
8 weeks
Secondary Outcomes (17)
All other questionnaires for baseline and follow up time points.
Baseline, 8 weeks
Influence factors for the completion rates
8 weeks
Influence factors for the completion rates
8 weeks
Influence factors for the completion rates
8 weeks
Influence factors for the completion rates
8 weeks
- +12 more secondary outcomes
Study Arms (2)
paper-based patient-reported-outcomes
on web-based patient-reported-outcomes
Interventions
Explorative pilot study combining collected data from the PRAEGNANT study on paper-based patient-reported-outcomes with additional collected data on web-based patient-reported-outcomes
Eligibility Criteria
The patient population for the paperbased PRO capture is part of the PRAEGNANT study population and shall comprize 100 patients, we aim to collect additional web based ePRO datasets for 200 patients
You may qualify if:
- Patients enrolled in PRAEGNANT
- Women aged ≥18 years
- Patients with the diagnosis metastasized breast cancer undergoing any form of systemic therapy
- Patients who are willing and able to sign the informed consent form
- Patients with therapy change
You may not qualify if:
- Patients who are not eligible for observation due to severe comorbidities or unavailability according to the treating physician
- Patients who are not able to handle a tablet computer or are unable to write
- Patients who are not able to understand the nature and extent of the trial and the procedures require
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University Hospital Tuebingenlead
- National Center for Tumor Diseases (NCT), University Hospital Heidelberg, Germanycollaborator
- Department of Gynecology and Obstetrics, University Hospital Heidelberg, Germanycollaborator
- Department of Gynecology and Obstetrics, University Hospital Erlangen, Germanycollaborator
Study Sites (1)
Department for Women's Health
Tübingen, 72076, Germany
Related Publications (1)
Wallwiener M, Matthies L, Simoes E, Keilmann L, Hartkopf AD, Sokolov AN, Walter CB, Sickenberger N, Wallwiener S, Feisst M, Gass P, Fasching PA, Lux MP, Wallwiener D, Taran FA, Rom J, Schneeweiss A, Graf J, Brucker SY. Reliability of an e-PRO Tool of EORTC QLQ-C30 for Measurement of Health-Related Quality of Life in Patients With Breast Cancer: Prospective Randomized Trial. J Med Internet Res. 2017 Sep 14;19(9):e322. doi: 10.2196/jmir.8210.
PMID: 28912116DERIVED
Related Links
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
April 12, 2017
First Posted
April 28, 2017
Study Start
June 1, 2017
Primary Completion
July 17, 2024
Study Completion
July 17, 2024
Last Updated
January 22, 2025
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share